ArticleBiochemical genetics2026
Network Pharmacology and Experimental Validation Reveal Wu Miao Pill's Therapeutic Effects on Acute Gouty Arthritis Through P2X7R Regulation.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute gouty arthritis (AGA) is a common inflammatory joint disease with limited therapeutic options and notable side effects from conventional treatments. This study investigated the anti-inflammatory effects and underlying mechanisms of the traditional Chinese herbal formula Wu Miao Pill (WMP) in a rat model of AGA induced by monosodium urate crystals. WMP administration markedly alleviated joint inflammation and swelling, improved synovial histopathology, and reduced the expression of P2X7 receptor (P2X7R) and pro-inflammatory cytokines IL-1β, IL-18, and TNF-α. P2X7R inhibition and knockdown experiments confirmed its central role in the therapeutic effect of WMP. Network pharmacology further revealed multiple active compounds targeting inflammatory pathways, notably IL-17 and NF-κB signaling. Overall, WMP exhibits significant anti-inflammatory efficacy through modulation of P2X7R and related pathways, providing experimental and mechanistic evidence for its potential as a novel therapeutic agent for AGA.
Indexed as
Identifiers
41351812What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.